Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 757.16M | $ 691.66M | $ 65.5M | $ 0 |
3/31/2025 | $ 784.56M | $ 721.99M | $ 62.57M | $ 0 |
12/31/2024 | $ 615.89M | $ 561.38M | $ 54.51M | $ 0 |
9/30/2024 | $ 579.27M | $ 532.13M | $ 47.14M | $ 0 |
6/30/2024 | $ 455.02M | $ 407.07M | $ 47.95M | $ 0 |
3/31/2024 | $ 485.82M | $ 443.65M | $ 42.16M | $ 0 |
12/31/2023 | $ 370.02M | $ 332.36M | $ 37.67M | $ 0 |
9/30/2023 | $ 326.25M | $ 289.11M | $ 37.14M | $ 0 |
6/30/2023 | $ 356.31M | $ 323.35M | $ 32.95M | $ 0 |
3/31/2023 | $ 384.44M | $ 352.76M | $ 31.68M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for KEROS THERAPEUTICS INC is calculated as follows: Assets [ $ 138.25M ] - Intangibles [ $ 0 ] - CashnEq [ $ 133.93M ]
(=) Core Assets [ $ 4.32M ]
Minimum
Mar 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.38M |
median | $ 287.61M |
std | $ 1.05B |